About: Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Sector: Healthcare
Industry: Biotechnology
Latest price: $257.93 (+3.10%)
ASND NASDAQ Ascendis Pharma AS
Ascendis Pharma AS share price
ASND price activity
Last Price
$257.930
Change (24hr)
7.76 USD (3.10%)
Volume
653.07K
Volume (4w avg)
-
Open
$252.50
Day Range
$248.34 - $257.93
Previous Close
$250.17
Last Trade
04 Nov, 9:00 pm GMT+0
Delayed
04 Nov, 9:00 pm GMT+0
ASND price performance
Delayed
04 Nov, 9:00 pm GMT+0
ASND details
ASND Market Signals